Treatment of autoimmune myasthenia gravis.
Bragdon
Andrew C
AC
D001323:Autoantibodies / Q000276:immunology; D020274:Autoimmune Diseases of the Nervous System / Q000276:immunology / Q000628:therapy*; D015415:Biomarkers; D006801:Humans; D009157:Myasthenia Gravis / Q000276:immunology / Q000628:therapy*; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology; D011950:Receptors, Cholinergic / Q000276:immunology
D001323:Autoantibodies; D015415:Biomarkers; D011950:Receptors, Cholinergic; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases